Literature DB >> 25325300

Sex differences among opioid-abusing patients with chronic pain in a clinical trial.

Jeanne Manubay1, Jesse Davidson, Suzanne Vosburg, Jermaine Jones, Sandra Comer, Maria Sullivan.   

Abstract

BACKGROUND: The characteristics of patients with co-occurring chronic pain and prescription opioid abuse have not been well described, and even less is known about differences between men and women in this population.
OBJECTIVES: This study evaluated sex differences in the demographic, diagnostic, and behavioral attributes of patients with chronic pain and opioid abuse.
METHODS: Data were collected via self-report and semistructured clinical interviews from 162 patients (120 men and 42 women) who screened for a study investigating the abuse liability of prescription opioids.
RESULTS: There were no differences between men and women in age, race, education, marital status, or employment status. Participants had used prescription opioids for 5.4 ± 6.7 years. The majority of participants (60%) had low back pain in addition to opioid dependence as defined by the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition. More women reported more arthritic pain than men, but otherwise there were no differences in types of pain. Pain exerted a greater effect in women on mood, walking ability, and social relations. Men reported more of certain aberrant behaviors, including abuse of alcohol or illicit drugs, unauthorized dose increases, contact with street culture, and being arrested by police. Women were more depressed than men.
CONCLUSIONS: The demographic profile of opioid-abusing patients with chronic pain presenting for treatment in a clinical trial was similar between sexes; however, some important differences were observed. Women reported more psychiatric comorbidity and endorsed greater pain-related physical and social impairment. Men reported more aberrant behaviors. These differences suggest that men with chronic pain and opioid abuse/dependence may benefit by closer monitoring of aberrant behaviors whereas women may benefit from closer attention paid to physical and psychological effects of pain.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25325300      PMCID: PMC4310755          DOI: 10.1097/ADM.0000000000000086

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  34 in total

1.  Gender and prescription opioids: findings from the National Survey on Drug Use and Health.

Authors:  Sudie E Back; Rebecca L Payne; Annie N Simpson; Kathleen T Brady
Journal:  Addict Behav       Date:  2010-06-22       Impact factor: 3.913

2.  Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial.

Authors:  Sudie E Back; Rebecca L Payne; Amy Herrin Wahlquist; Rickey E Carter; Zachary Stroud; Louise Haynes; Maureen Hillhouse; Kathleen T Brady; Walter Ling
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09       Impact factor: 3.829

3.  Sex differences in long-term opioid use: cautionary notes for prescribing in women.

Authors:  Beth D Darnall; Brett R Stacey
Journal:  Arch Intern Med       Date:  2012-03-12

4.  Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers.

Authors:  Jeffrey H Coben; Stephen M Davis; Paul M Furbee; Rosanna D Sikora; Roger D Tillotson; Robert M Bossarte
Journal:  Am J Prev Med       Date:  2010-05       Impact factor: 5.043

5.  Gender differences in risk factors for aberrant prescription opioid use.

Authors:  Robert N Jamison; Stephen F Butler; Simon H Budman; Robert R Edwards; Ajay D Wasan
Journal:  J Pain       Date:  2009-11-27       Impact factor: 5.820

6.  Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.

Authors:  Perrine Roux; Maria A Sullivan; Julien Cohen; Lionel Fugon; Jermaine D Jones; Suzanne K Vosburg; Ziva D Cooper; Jeanne M Manubay; Shanthi Mogali; Sandra D Comer
Journal:  Pain       Date:  2013-05-07       Impact factor: 6.961

7.  Evaluation of potential sex differences in the subjective and analgesic effects of morphine in normal, healthy volunteers.

Authors:  Sandra D Comer; Ziva D Cooper; William J Kowalczyk; Maria A Sullivan; Suzette M Evans; Adam M Bisaga; Suzanne K Vosburg
Journal:  Psychopharmacology (Berl)       Date:  2009-10-27       Impact factor: 4.530

8.  Psychiatric morbidity in pain conditions: results from the Singapore Mental Health Study.

Authors:  Mythily Subramaniam; Janhavi Ajit Vaingankar; Edimansyah Abdin; Siow Ann Chong
Journal:  Pain Res Manag       Date:  2013 Jul-Aug       Impact factor: 3.037

9.  Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients.

Authors:  Joseph O Merrill; Michael Von Korff; Caleb J Banta-Green; Mark D Sullivan; Kathleen W Saunders; Cynthia I Campbell; Constance Weisner
Journal:  Gen Hosp Psychiatry       Date:  2012-09-05       Impact factor: 3.238

10.  Vital signs: overdoses of prescription opioid pain relievers and other drugs among women--United States, 1999-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-07-05       Impact factor: 17.586

View more
  18 in total

1.  Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III.

Authors:  Bradley T Kerridge; Tulshi D Saha; S Patricia Chou; Haitao Zhang; Jeesun Jung; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2015-09-02       Impact factor: 4.492

Review 2.  Sex differences in prescription opioid use.

Authors:  Mirsada Serdarevic; Catherine W Striley; Linda B Cottler
Journal:  Curr Opin Psychiatry       Date:  2017-07       Impact factor: 4.741

3.  Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015.

Authors:  Mir M Ali; Eli Cutler; Ryan Mutter; Rachel Mosher Henke; Peggy L O'Brien; Jesse M Pines; Maryann Mazer-Amirshahi; Jared Diou-Cass
Journal:  J Med Toxicol       Date:  2019-05-31

4.  Repeated Morphine Produces Sensitization to Reward and Tolerance to Antiallodynia in Male and Female Rats with Chemotherapy-Induced Neuropathy.

Authors:  L P Legakis; S S Negus
Journal:  J Pharmacol Exp Ther       Date:  2018-01-23       Impact factor: 4.030

5.  Drug Overdose: Differing Risk Models for Women and Men among Opioid Users with Non-Cancer Pain.

Authors:  Yuanyuan Liang; Martin W Goros; Barbara J Turner
Journal:  Pain Med       Date:  2016-04-28       Impact factor: 3.750

6.  Gender differences in use of prescription narcotic medications among living kidney donors.

Authors:  Krista L Lentine; Ngan N Lam; Mark A Schnitzler; Amit X Garg; Huiling Xiao; Sheila E Leander; Daniel C Brennan; Sandra J Taler; David Axelrod; Dorry L Segev
Journal:  Clin Transplant       Date:  2015-09-18       Impact factor: 2.863

7.  Pain-related anxiety, sex, and co-use of alcohol and prescription opioids among adults with chronic low back pain.

Authors:  Lisa R LaRowe; Jessica M Powers; Lorra Garey; Andrew H Rogers; Michael J Zvolensky; Joseph W Ditre
Journal:  Drug Alcohol Depend       Date:  2020-07-10       Impact factor: 4.492

8.  Chronic non-cancer pain among adults with substance use disorders: Prevalence, characteristics, and association with opioid overdose and healthcare utilization.

Authors:  William S John; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2020-02-11       Impact factor: 4.492

Review 9.  Neuronal and glial factors contributing to sex differences in opioid modulation of pain.

Authors:  Dayna L Averitt; Lori N Eidson; Hillary H Doyle; Anne Z Murphy
Journal:  Neuropsychopharmacology       Date:  2018-06-23       Impact factor: 7.853

10.  Can neuroimaging help combat the opioid epidemic? A systematic review of clinical and pharmacological challenge fMRI studies with recommendations for future research.

Authors:  Hestia Moningka; Sarah Lichenstein; Patrick D Worhunsky; Elise E DeVito; Dustin Scheinost; Sarah W Yip
Journal:  Neuropsychopharmacology       Date:  2018-10-03       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.